In breast tumors, the methylation status at the ZNF217 gene promoter correlated with ZNF217 gene-expression levels [24, 51] while in peripheral blood cells, lack of methylation at the ZNF217 locus predicted breast cancer risk (p = 0.006) [76]. Here, ZNF217 is linked to breast cancer.